Adam D. Cohen, MD, Discusses Therapy Options for Multiple Myeloma
Adam D. Cohen, MD, Director, Myeloma Immunotherapy, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, shares his thoughts on several abstracts presented at the 2018 ASH Annual Meeting that pertained to therapy options for multiple myeloma.
Listen to the entire 3-part podcast series below.
Dr Cohen shares data from several studies that explored the use of daratumamab earlier in multiple myeloma treatment.
Dr Cohen discusses a few promising immunotherapy approaches for patients with multiple myeloma.
Dr Cohen shares data from a study looking at ixazomib as a maintenance therapy option for patients with multiple myeloma.